Placebo News and Research

RSS

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

3 Sep 2019

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Beta-blockers remain effective for preventing death in heart failure with reduced ejection fraction (HFrEF) and sinus rhythm, even in patients with moderate or moderately-severe kidney dysfunction, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology.

3 Sep 2019

White matter influences how people respond to non-invasive electrical brain stimulation

Tiny changes in the microscopic structure of the human brain may affect how patients respond to an emerging therapy for neurological problems.

29 Aug 2019

New drug shows promise to improve effects of psychological treatment for PTSD

A medication that boosts the body's own cannabis-like substances, endocannabinoids, shows promise to help the brain un-learn fear memories when these are no longer meaningful.

29 Aug 2019

Investigational drug reduces stuttering symptoms in open-label pilot study

A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.

28 Aug 2019

High-protein bedtime snacks do not disturb overnight fat metabolism for active women

Physically active women who have foresworn bedtime snacks should feel no fear cracking open the cupboards after sundown for a protein-rich treat, according to new Florida State University-led research.

28 Aug 2019

Promising vaccine may protect against the Klebsiella superbug

A powerful superbug, a hypervirulent form of the bacteria Klebsiella pneumoniae, is a very difficult to curb infection. It causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections.

28 Aug 2019

Excess body fat linked to greater risk of developing depression

Carrying ten kilograms of excess body fat increases the risk of depression by seventeen per cent. The more fat, the greater the probability of developing depression. This is the main conclusion of a new study carried out by researchers from Aarhus University and Aarhus University Hospital, Denmark.

27 Aug 2019

Addiction clinics market pricey, unproven treatments to desperate patients

Jason was hallucinating. He was withdrawing from drugs at an addiction treatment center near Indianapolis, and he had hardly slept for several days.

23 Aug 2019

Yale study shows rt-fMRI-NF has potential to treat adolescents with Tourette Syndrome

Characterized by repetitive movements or vocalizations known as tics, Tourette Syndrome is a neurodevelopmental disorder that plagues many adolescents.

21 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

MRI scans show how ADHD medication affects brain structure in children

MRI scans have revealed that children taking the medication methylphenidate experience alterations in the distribution of white matter in the brain.

15 Aug 2019

New AAN guidelines includes recommendations for treatment of migraine in children, teens

For children and teens with migraine, the pain and symptoms that accompany migraine attacks can be debilitating, resulting in missed school days, absence from social or sporting events, and affected home activities.

14 Aug 2019

Chlamydia vaccine shows promise after a successful clinical trial

A vaccine against the sexually transmitted infection (STI) chlamydia is now a substantial step closer to reality after successfully passing its Phase 1 clinical trial.

14 Aug 2019

BrainHealth research explores the neurochemistry of social perception

Cues signaling trust and dominance are crucial for social life. Recent research from Dr. Dan Krawczyk's lab at the Center for BrainHealth explored whether administering two chemically similar hormones known to affect social cognition - oxytocin and vasopressin - would influence the perception of trustworthiness and/or social dominance.

9 Aug 2019

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

The use of prescription stimulants by those without medically diagnosed conditions marks a growing trend among young adults – particularly college students seeking a brain boost.

9 Aug 2019

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

New injection helps reduce body weight, glucose levels in patients with obesity

An injection has helped reduce body weight and glucose levels in patients with diabetes and obesity in four weeks.

6 Aug 2019

Superstar athletes popularize unproven stem cell procedures

Baseball superstar Max Scherzer — whose back injury has prevented him from pitching for the Washington Nationals since he last played on July 25 — is the latest in a long list of professional athletes to embrace unproven stem cell injections in an attempt to accelerate their recovery.

5 Aug 2019

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

3 Aug 2019

Placebo News and Research

Ticagrelor reduces heart attacks and strokes for patients with diabetes

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

White matter influences how people respond to non-invasive electrical brain stimulation

New drug shows promise to improve effects of psychological treatment for PTSD

Investigational drug reduces stuttering symptoms in open-label pilot study

High-protein bedtime snacks do not disturb overnight fat metabolism for active women

Promising vaccine may protect against the Klebsiella superbug

Excess body fat linked to greater risk of developing depression

Addiction clinics market pricey, unproven treatments to desperate patients

Yale study shows rt-fMRI-NF has potential to treat adolescents with Tourette Syndrome

FDA approves new drug to treat patients with myelofibrosis

MRI scans show how ADHD medication affects brain structure in children

New AAN guidelines includes recommendations for treatment of migraine in children, teens

Chlamydia vaccine shows promise after a successful clinical trial

BrainHealth research explores the neurochemistry of social perception

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

Researchers test new drug to treat patients with chylomicronemia syndrome

New injection helps reduce body weight, glucose levels in patients with obesity

Superstar athletes popularize unproven stem cell procedures

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News